Carisma Therapeutics Inc.

Ownership Transactions Reported by 28 Insiders

Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Suite 401, Philadelphia, PA

Insiders trading volume in the past year

Carisma Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Klichinsky Chief Scientific Officer $0 -$139K -100% Oct 7, 2025
David Scadden Director Jul 1, 2024
Marella Thorell Director Jul 1, 2024
Sohanya Cheng Director Oct 31, 2024
Natalie McAndrew Vice President of Finance Jan 1, 2025
Sanford Zweifach Director Jun 26, 2024
ModernaTX, Inc. 10%+ Owner Mar 7, 2023
Steven Kelly President and CEO, Director Jan 28, 2025
Briggs Morrison Director Jun 26, 2024
Richard Morris Chief Financial Officer Jun 17, 2024
Michael Torok Director Jun 26, 2024
Bjorn Odlander Director Mar 7, 2023
Regina Hodits Director Mar 7, 2023
Chidozie Ugwumba Director Jun 6, 2023
John Hohneker Director Jun 26, 2024
Peter Honig Director Jun 22, 2022
Elly Ryu Principal Accounting Officer Mar 2, 2023
A. Jewett Michael Director Jun 22, 2022
Minori Rosales Chief Development Officer Jan 24, 2022
Jason A. Keyes Director Jun 22, 2022
Glen C. MacDonald Chief Technology Officer Mar 2, 2023
Mark Sullivan General Counsel & Secretary Mar 2, 2023
Jay S. Duker Director Jun 22, 2022
Monica Forbes Chief Financial Officer Mar 2, 2023
Jane Henderson Director May 3, 2021
Carrie L. Bourdow Director Jun 22, 2022
Patricia M. Drake Chief Commercial Officer Jun 1, 2021
Thomas R. Cannell President and CEO, Director Mar 2, 2023

Recent Insider Transactions by Companies or Individuals for Carisma Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.